Arrowhead Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript
Good afternoon, everyone, and thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Michael Ulz, one of the biotech analysts here. And it's my pleasure to introduce Vince Anzalone, VP of Finance and Investor Relations. Just a reminder, the format for today is a fireside chat. Before we get started, I just need to read a quick disclosure.
For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representatives. With that, Vince, thanks for joining us today, and maybe I'll just hand it over to you to make some brief intro comments on Arrowhead.
Sure. Thanks, Mike, and thank you to all of Morgan Stanley for having us today. So Arrowhead Pharmaceuticals, we're
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |